Q1 2017 Halozyme Therapeutics Inc Earnings Call

9/5/2017 16:30

Conference Call Halozyme Therapeutics Inc

Halozyme Therapeutics Inc Conference call or earnings call will be held on May 9, 2017 During the earnings conference call's session Halozyme Therapeutics Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conference call the bridge access number and key in the PIN code, Contact Halozyme Therapeutics Inc for this information
Schedule a conference call with QCONF and get 5 free conference calls.
Halozyme Therapeutics, Inc. is a biotechnology company focused on developing and commercializing novel oncology therapies. We are seeking to translate our unique knowledge of the tumor microenvironment to create therapies that have the potential to improve cancer patient survival. Our research primarily focuses on human enzymes that alter the extracellular matrix and tumor microenvironment. The extracellular matrix is a complex matrix of proteins and carbohydrates surrounding the cell that provides structural support in tissues and orchestrates many important biological activities, including cell migration, signaling and survival. Over many years, we have developed unique technology and scientific expertise enabling us to pursue this target-rich environment for the development of therapies.    
Read more Conference Call

Halozyme Therapeutics Inc (HALO)

11388 Sorrento Valley Road, San Diego California 92121, United States